NCT04207034

Brief Summary

The objective of the present study is

  1. 1.To study the incidence and magnitude of bacteremia after periodontal flap surgery .
  2. 2.To compare and evaluate the effect of diode laser on frequency of bacteremia associated with periodontal flap surgery .
  3. 3.To study the incidence of bacteremia after laser therapy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2021

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

12 months

First QC Date

December 10, 2019

Last Update Submit

December 16, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of bacteremia using PCR

    Bacteremia in venous blood before starting the procedure, after 5 minutes and within 30 minutes of the start of the procedure

    After 24 hours of collection

Study Arms (2)

flap surgery and diode laser

EXPERIMENTAL

Patient will be asked to rinse with 0.2% chlorhexidine mouthwash. Following the administration of local anaesthesia 2% lignocaine hydrochloride ( with 1: 80,000 epinephrine) , Laser application will be carried out , with the help of 810 nm (A.R.C LASER FoxTM) diode laser with a flexible optic tip of 300µm . The sulci will be lased with a repeated beam ( 0.2 sec on 0.3 sec off) at an output power of 1.0 W. Intracrevicular incision will be placed with the help of 15c Bard Parker surgical blade , full thickness mucoperiosteal flap will be elevated . Debridement of granulation tissue will be done and flap will be suture back in position using 3-0 black breaded silk suture, the site will be covered with non eugenol periodontal dressing for protection. Postoperative instructions will be given to the patient. 2 ml blood will be collected at baseline(sample 1) , at 5 minutes (sample 2) and within 20-30 minutes (sample 3) of starting the procedure.

Procedure: flap surgery with diode laser

flap surgery

ACTIVE COMPARATOR

Patient will be asked to rinse with 0.2% chlorhexidine mouthwash. Following the administration of local anaesthesia 2% lignocaine hydrochloride ( with 1:80,000 epinephrine) ,intracrevicular incision will be placed with the help of 15c Bard Parker surgical blade , full thickness mucoperiosteal flap will be elevated . Debridement of granulation tissue will be done and flap will be suture back in position using 3-0 black breaded silk suture, the site will be covered with non eugenol periodontal dressing for protection. Postoperative instructions will be given to the patient. 2 ml blood will be collected at baseline(sample 1) , at 5 minutes (sample 2) and within 20-30 minutes (sample 3) of starting the procedure

Procedure: flap surgery

Interventions

Patient will be asked to rinse with 0.2% chlorhexidine mouthwash. Following the administration of local anaesthesia 2% lignocaine hydrochloride ( with 1: 80,000 epinephrine) , Laser application will be carried out , with the help of 810 nm (A.R.C LASER FoxTM) diode laser with a flexible optic tip of 300µm . The sulci will be lased with a repeated beam ( 0.2 sec on 0.3 sec off) at an output power of 1.0 W. Intracrevicular incision will be placed with the help of 15c Bard Parker surgical blade , full thickness mucoperiosteal flap will be elevated . Debridement of granulation tissue will be done and flap will be suture back in position using 3-0 black breaded silk suture, the site will be covered with non eugenol periodontal dressing for protection. Postoperative instructions will be given to the patient. 2 ml blood will be collected at baseline(sample 1) , at 5 minutes (sample 2) and within 20-30 minutes (sample 3) of starting the procedure.

flap surgery and diode laser
flap surgeryPROCEDURE

Patient will be asked to rinse with 0.2% chlorhexidine mouthwash. Following the administration of local anaesthesia 2% lignocaine hydrochloride ( with 1:80,000 epinephrine) ,intracrevicular incision will be placed with the help of 15c Bard Parker surgical blade , full thickness mucoperiosteal flap will be elevated . Debridement of granulation tissue will be done and flap will be suture back in position using 3-0 black breaded silk suture, the site will be covered with non eugenol periodontal dressing for protection. Postoperative instructions will be given to the patient. 2 ml blood will be collected at baseline(sample 1) , at 5 minutes (sample 2) and within 20-30 minutes (sample 3) of starting the procedure

flap surgery

Eligibility Criteria

Age30 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patient with age 30 -40 years .
  • Systemically healthy patients.
  • Patients having probing depth of ≥ 5mm and ≤ 8 mm at minimum of two sites and good level of oral hygiene after initial therapy.
  • No signs of gingival inflammation

You may not qualify if:

  • Patient with history of smoking, antibiotic therapy within the previous three months.
  • Patient with subgingival restorations and use of antiseptic mouthwash.
  • Congenital or acquired cardiac defects, cardiac prosthesis.
  • Hematological disorder.
  • Immunocompromised patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MLV Prabhuji

Bangalore, Karnataka, 562157, India

Location

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Lasers, Semiconductor

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Akanksha Dubey, MDS

    Rajiv Gandhi University of Health Sciences

    PRINCIPAL INVESTIGATOR
  • MLV Prabhuji, MDS

    Rajiv Gandhi University of Health Sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double (investigator and outcome Assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study was performed according to split- mouth design, and all teeth in the mouth were treated randomly using either the left or the right side of the maxilla and mandible for control , and the opposite side for the therapy. Each patient was entered into a clinical protocol consisting of two different treatment modalities. Group I (n=10) - Test group ( diode laser + flap surgery) Group II (n=10) - control group (flap surgery)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
proffesor/ Head of the department Periodontology

Study Record Dates

First Submitted

December 10, 2019

First Posted

December 20, 2019

Study Start

January 1, 2020

Primary Completion

December 30, 2020

Study Completion

January 10, 2021

Last Updated

December 17, 2020

Record last verified: 2020-12

Locations